Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: Implications for transmission and pathogenesis

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 8273-8280

  Riley, James L ^a   Levine, Bruce L ^b   Craighead, Nancy ^c   Francomano, Tara ^b   Kim, Daniel ^b   Carroll, Richard G ^b   June, Carl H ^b,c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; BETA CHEMOKINE; CD3 ANTIGEN; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; PRIMER DNA; VIRUS RECEPTOR;

ARTICLE; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; GENE EXPRESSION; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; MEMORY CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL; VIRUS REPLICATION; CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; DNA PRIMERS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; RECEPTORS, HIV; VIRUS REPLICATION;

EID: 0031595931     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.8273-8280.1998     Document Type: Article

References (71)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, K. B. Bacon, and C. G. Figdor. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713-717.
3. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
4. Amara, A., S. L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J. L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139-146.
5. + lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset. Blood 88:2626-2633.
6. Benito, J. M., J. M. Zabay, J. Gil, M. Bermejo, A. Escudero, E. Sanchez, and E. Fernandez-Cruz. 1997. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA. CD11b. CD38, HLA-DR, and CD25 antigens. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:128-135.
7. Beverley, P. 1991. Immunological memory in T cells. Curr. Opin. Immunol. 3:355-360.
8. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
9. Bretscher, P. 1992. The two-signal model of lymphocyte activation twentyone years later. Immunol. Today 13:74-76.
10. + T cells. Science 257:383-387.
11. Cameron, P. U., M. G. Lowe, F. Sotzik, A. F. Coughlan, S. M. Crowe, and K. Shortman. 1996. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J. Exp. Med. 183:1851-1856.
12. + T cells. Science 276:273-276.
13. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
14. + cells are not selectively decreased in chronic HIV disease. J. Acquired Immune Defic. Syndr. 7:665-675.
15. + T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. J. Virol. 71:4436-4444.
16. Clark, E. A. 1996. HIV: dendritic cells as embers for the infectious fire. Curr. Biol. 6:655-657.
17. + helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J. Immunol. 141:1464-1470.
18. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-581.
19. + T cells. Science 270:1811-1815.
20. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES. Eur. J. Immunol. 25:751-756.
21. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621-628.
22. Cornelissen, M., G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. van der Hoek, C. Sol, R. Coutinho, and J. Goudsmit. 1995. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69:1810-1818.
23. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
24. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
25. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
26. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
27. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
28. Forster, R., E. Kremmer, A. Schubel, D. Breitfeld, A. Kleinschmidt, C. Nerl, G. Bernhardt, and M. Lipp. 1998. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J. Immunol. 160:1522-1531.
29. Giorgi, J. V., and R. Detels. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52:10-18.
30. Hansen, J. A., P. J. Martin, and R. C. Nowinski. 1980. Monoclonal antibodies identifying a novel T-cell antigen and Ia antigens of human lymphocytes. Immunogenetics 10:247.
31. + T cells. Clin. Exp. Immunol. 107:300-305.
32. Herold, K. C., J. Lu, I. Rulifson, V. Vezys, D. Taub, M. J. Grusby, and J. A. Bluestone. 1997. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J. Immunol. 159:4150-4153.
33. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321-331.
34. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472-4481.
35. 1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol. 72:3161-3168.
36. Kung, P., G. Goldstein, E. L. Reinherz, and S. F. Schlossman. 1979. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206:347-349.
37. + T cells in the absence of exogenous feeder cells. J. Immunol. 159:5921-5930.
38. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272:1939-1943.
39. + T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7:891-904.
40. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569-577.
41. Mackay, C. R. 1993. Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:423-427.
42. Mahalingam, M., A. Pozniak, T. J. McManus, G. Senaldi, D. Vergani, and M. Peakman. 1996. Abnormalities of CD45 isoform expression in HIV infection. Clin. Immunol. Immunopathol. 81:210-214.
43. Mascola, J. R., J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
44. + T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells. J. Clin. Investig. 94:1947-1952.
45. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51-52.
46. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:3483-3491.
47. - selection on T cells during the virgin to memory cell transition. J. Immunol. 150:1105-1121.
48. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
49. Pope, M., M. G. Betjes, N. Romani, H. Hirmand, P. U. Cameron, L. Hoffman, S. Gezelter, G. Schuler, and R. M. Steinman. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78:389-398.
50. Prince, H. E., S. Kleinman, C. Czaplicki, J. John, and A. E. Williams. 1990. Interrelationships between serologic makers of immune activaion and T lymphocyte subsets in HIV infection. J. Acquired Immune Defic. Syndr. 3:525-530.
51. -) subsets in human immunodeficiency virus infection. J. Clin. Lab. Anal. 5:96-100.
52. Riley, J. L., R. G. Carroll, B. L. Levine, W. Bernstein, D. C. St. Louis, O. S. Weislow, and C. H. June. 1997. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158:5545-5553.
53. Riley, J. L., et al. Unpublished data.
54. Roederer, M. 1995. T-cell dynamics of immunodeficiency. Nat. Med. 1:621-622. (Comment.)
55. Roederer, M., J. G. Dubs, M. T. Anderson, P. A. Raju, and L. A. Herzenberg, 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Investig. 95:2061-2066.
56. Roederer, M., P. A. Raju, D. K. Mitra, and L. A. Herzenberg. 1997. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Investig. 99:1555-1564.
57. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
58. Samson, M., O. Labbe, C. Mollereau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362-3367.
59. + memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA 87:6058-6062.
60. Smith, S. H., M. H. Brown, D. Rowe, R. E. Callard, and P. C. Beverley. 1986. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 58:63-70.
61. Spina, C. A., H. E. Prince, and D. D. Richman. 1997. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Investig. 99:1774-1785.
62. Sprent, J., D. F. Tough, and S. Sun. 1997. Factors controlling the turnover of T memory cells. Immunol. Rev. 156:79-85.
63. Teitel, J. M., J. J. Freedman, M. B. Garvey, and M. Kardish. 1989. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1. Am. J. Hematol. 32:262-272.
64. Unutmaz, D., and D. R. Littman, 1997. Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing. Proc. Natl. Acad. Sci. USA 94:1615-1618.
65. Vahey, M. T., and M. T. Wong. 1995. Quantative liquid hybridization employing phosphor technology, p. 313-313. In C. W. Dieffenbach and G. S. Dveksler (ed.), PCR primer: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
66. Vahey, M. T., M. T. Wong, and N. L. Michael. 1995. A standard PCR protocol: rapid isolation of DNA and PCR assay for β-globin, p. 17. In C. W. Dieffenbach and G. S. Dveksler (ed.), PCR primer: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
67. Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. 1995. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA 92:11091-11094.
68. Woods, T. C., B. D. Roberts, S. T. Butera, and T. M. Folks. 1997. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 89:1635-1641.
69. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J. Exp. Med. 185:1681-1691.
70. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
71. + T lymphocytes. AIDS 9:561-566.